10 ML busulfan 6 MG/ML Injection — RxCUI 253113
RxNorm drug concept · Semantic clinical drug
RxCUI 253113
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI253113
Official name10 ML busulfan 6 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbusulfan 60 MG per 10 ML Injection; busulfan 60 MG in 10 ML Injection
FDA products mapped9
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Busulfan Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- BUSULFEX is a chemotherapy drug used to prepare your body for a stem cell transplant when you have chronic myelogenous leukemia, a type of blood cancer. It's given alongside anothe...
- BUSULFEX is given through a central IV line — a catheter placed in a large vein — as a slow infusion over two hours. You'll receive a dose every six hours for four days in a row, f...
- How is BUSULFEX given, and how long does the treatment take?
- Almost everyone experiences nausea, vomiting, mouth sores, diarrhea, fever, and significant fatigue — these are expected and your care team will help manage them. The more serious...
🕸️ Concept Web — How 10 ML busulfan 6 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML busulfan 6 MG/ML Injection
RxCUI 253113 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Busulfan
1828IN
-
Busulfan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Busulfex
284676BN
-
Busulfex
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Busulfan Injection
1729351SCDF -
Busulfan Injectable Product
1151374SCDG -
Busulfan Injection [Busulfex]
1729353SBDF -
Busulfex Injectable Product
1168702SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Busulfan Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Busulfan 6 MG/ML
315503SCDC -
10 ML busulfan 6 MG/ML Injection [Busulfex]
284425SBD -
Busulfan 6 MG/ML [Busulfex]
574864SBDC
-
Busulfan 6 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Busulfan 6 MG/ML
SCDC · 315503 -
Busulfan Injection
SCDF · 1729351 -
Busulfan Injectable Product
SCDG · 1151374
Brand-Name Concepts
-
10 ML busulfan 6 MG/ML Injection [Busulfex]
SBD · 284425 -
Busulfan 6 MG/ML [Busulfex]
SBDC · 574864 -
Busulfan Injection [Busulfex]
SBDF · 1729353 -
Busulfex Injectable Product
SBDG · 1168702 -
Busulfex
BN · 284676
📦 FDA Products & Package NDCs
9 products · 9 package NDCs
9 package NDCs map to RxCUI 253113 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-1112-01 | 8 CARTON in 1 CARTON (0409-1112-01) / 1 VIAL, SINGLE-DOSE i... | BUSULFAN | Hospira, Inc. | 2019-02-28 |
| 16729-0351-92 | 8 VIAL, SINGLE-DOSE in 1 CARTON (16729-351-92) / 10 mL in 1... | Busulfan | Accord Healthcare, Inc | 2019-07-22 |
| 25021-0241-10 | 8 VIAL in 1 CARTON (25021-241-10) / 10 mL in 1 VIAL | Busulfan | Sagent Pharmaceuticals | 2017-05-15 |
| 51817-0170-01 | 8 VIAL in 1 PACKAGE (51817-170-01) / 10 mL in 1 VIAL | Busulfan | Pharmascience Inc. | 2017-05-19 |
| 55150-0395-08 | 8 VIAL, SINGLE-DOSE in 1 CARTON (55150-395-08) / 10 mL in 1... | Busulfan | Eugia US LLC | 2024-06-25 |
| 59148-0070-91 | 8 CARTON in 1 CARTON (59148-070-91) / 1 VIAL in 1 CARTON (5... | BUSULFEX | Otsuka America Pharmaceutical, Inc. | 1999-02-04 |
| 70121-1244-07 | 8 VIAL, SINGLE-DOSE in 1 CARTON (70121-1244-7) / 10 mL in 1... | Busulfan | Amneal Pharmaceuticals LLC | 2017-12-18 |
| 71288-0116-11 | 8 VIAL, SINGLE-DOSE in 1 CARTON (71288-116-11) / 10 mL in 1... | Busulfan | Meitheal Pharmaceuticals Inc. | 2020-10-23 |
| 71288-0158-96 | 8 VIAL, SINGLE-DOSE in 1 CARTON (71288-158-96) / 10 mL in 1... | Busulfan | Meitheal Pharmaceuticals Inc. | 2020-10-23 |
Observed labelers:
Meitheal Pharmaceuticals Inc. (2) ·
Accord Healthcare, Inc (1) ·
Amneal Pharmaceuticals LLC (1) ·
Eugia US LLC (1) ·
Hospira, Inc. (1) ·
Otsuka America Pharmaceutical, Inc. (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0594 | Busulfan injection | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.